Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsDROPSStandard

NETARSUDIL MESYLATE

NETARSUDIL

Standard Dose
0.02%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NETARSUDIL MESYLATE is listed in Drugs@FDA under application 216855 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NETARSUDIL Form and strength SOLUTION;DROPS - 0.02% Sponsor GLAND PHARMA LTD Submission history Latest submission status date: 2024-01-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview NETARSUDIL MESYLATE is listed in Drugs@FDA under application 216855 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NETARSUDIL Form and strength SOLUTION;DROPS - 0.02% Sponsor GLAND PHARMA LTD Submission history Latest submission status date: 2024-01-05 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
NETARSUDIL MESYLATE (NETARSUDIL) | Drug Monograph | MedicHelpline